Extracorporeal Shockwave Therapy for Patients with Chronic Achilles Tendinopathy in Long or Short Course

被引:5
|
作者
Yan, BaiLi [1 ]
Wan, Yuan [1 ]
Zhang, Hong [1 ]
Pan, MengTing [1 ]
Zhou, Cheng [2 ]
机构
[1] Wuhan 1 Hosp, Dept Pain Management, Wuhan, Peoples R China
[2] Wuhan 1 Hosp, Dept Hepatobiliary Surg, Wuhan, Peoples R China
关键词
WAVE THERAPY;
D O I
10.1155/2020/7525096
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Object. In this study, our aim is to evaluate the efficiency of extracorporeal shockwave therapy (ESWT) on chronic Achilles tendinopathy (CAT) with different courses of disease. Methods. The data of 66 patients with CAT received ESWT was reviewed. According to the disease courses, those cases were allocated to short-term group (ST group, symptom duration 3-6 months) and long-term group (LT group, symptom duration >6 months). Propensity scores match (PSM) method was conducted to eliminate the confound factors in baseline features including gender, sport history, sides, type of CAT, BMI (body mass index), age, and scores evaluated by AOFAS (American Orthopedic Foot and Ankle Society) and VAS (Visual Analogue Scale) before ESWT. After balancing the features between ST and LT group, postinterventional VAS, AOFAS, and rate of Likert satisfaction scale at the 3rd month after first ESWT was statistically analyzed. Results. Among the baseline features in ST and LT group, gender (female ratio, 44.4% vs 71.4%, p = 0.041) and BMI (23.26 +/- 2.15 vs 24.63 +/- 2.41, p = 0.024) were identified as confound factors. After elimination of biased features with PSM, 3 months after first ESWT, AOFAS and VAS in both groups are significantly improved, when compared with their scores at baseline (p < 0.01). Moreover, at postintervention month 3 (PIM3), AOFAS in ST group is significantly higher than LT group (85.08 +/- 9.83 vs 76.76 +/- 9.85, t = 76.76 +/- 9.85, p = 0.019), and the rate of Likert satisfaction in ST group is better than LT group; although, it did not reach but close to significant level (70.6% vs 47.1%,.2 = 1.943, p = 0.163). However, there is no statistical difference of VAS scores between two groups after ESWT (1.96 +/- 0.98 vs 2.24 +/- 1.29, t = 0.703, p = 0.487). Conclusions. ESWT could effectively relieve pain and improve function of hind foot in patients with chronic Achilles tendinopathy, and especially, it could offer better benefit on functional improvement in patients with short duration of CAT symptom.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Extracorporeal shockwave therapy for patellar tendinopathy: a review of the literature
    van Leeuwen, M. T.
    Zwerver, J.
    van den Akker-Scheek, I.
    [J]. BRITISH JOURNAL OF SPORTS MEDICINE, 2009, 43 (03) : 163 - 168
  • [22] The Effectiveness of Extracorporeal Shock Wave Therapy on Chronic Achilles Tendinopathy: A Systematic Review
    Al-Abbad, Hani
    Simon, Joel Varghese
    [J]. FOOT & ANKLE INTERNATIONAL, 2013, 34 (01) : 33 - 41
  • [23] Shockwave therapy for chronic Achilles tendinopathy - A double-blind, randomized clinical trial of efficacy
    Rasmussen, Sten
    Christensen, Marianne
    Mathiesen, Iben
    Simonsen, Ole
    [J]. ACTA ORTHOPAEDICA, 2008, 79 (02) : 249 - 256
  • [24] Extracorporeal Shockwave Therapy for Mid-portion and Insertional Achilles Tendinopathy: A Systematic Review of Randomized Controlled Trials
    Marc A. Paantjens
    Pieter H. Helmhout
    Frank J. G. Backx
    Faridi S. van Etten-Jamaludin
    Eric W. P. Bakker
    [J]. Sports Medicine - Open, 2022, 8
  • [25] Extracorporeal Shockwave Therapy for Mid-portion and Insertional Achilles Tendinopathy: A Systematic Review of Randomized Controlled Trials
    Paantjens, Marc A.
    Helmhout, Pieter H.
    Backx, Frank J. G.
    van Etten-Jamaludin, Faridi S.
    Bakker, Eric W. P.
    [J]. SPORTS MEDICINE-OPEN, 2022, 8 (01)
  • [26] The effects of extracorporeal shockwave therapy on matrix metalloprotease activity in tendinopathy
    Waugh, Charlie
    Jones, Eleanor
    Riley, Graham
    Langberg, Henning
    Morrissey, Dylan
    Screen, Hazel
    [J]. FASEB JOURNAL, 2014, 28 (01):
  • [27] IN VIVO BIOLOGICAL RESPONSE TO EXTRACORPOREAL SHOCKWAVE THERAPY IN HUMAN TENDINOPATHY
    Waugh, C. M.
    Morrissey, D.
    Jones, E.
    Riley, G. P.
    Langberg, H.
    Screen, H. R. C.
    [J]. EUROPEAN CELLS & MATERIALS, 2015, 29 : 268 - 280
  • [28] Extracorporeal Shockwave Therapy for the Treatment of Achilles Tendinopathies A Prospective Study
    Fridman, Robert
    Cain, Jarrett D.
    Weil, Lowell, Jr.
    Weil, Lowell, Sr.
    [J]. JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2008, 98 (06) : 466 - 468
  • [29] High-energy extracorporeal shock wave therapy as a treatment for chronic noninsertional Achilles tendinopathy
    Furia, John P.
    [J]. AMERICAN JOURNAL OF SPORTS MEDICINE, 2008, 36 (03): : 502 - 508
  • [30] Combined extracorporeal shockwave therapy and exercise for the treatment of tendinopathy: A narrative review
    Burton, Ian
    [J]. SPORTS MEDICINE AND HEALTH SCIENCE, 2022, 4 (01) : 8 - 17